ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
In a preliminary review of blinded data from the ongoing TREK-DX study, 45% (10/22) of patients achieved at least a…
Pharmaceuticals, Biotechnology and Life Sciences
In a preliminary review of blinded data from the ongoing TREK-DX study, 45% (10/22) of patients achieved at least a…
MALVERN, Pa., April 12, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused…
Jeremy Gowler appointed Interim CEOWALTHAM, Mass., April 12, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on…
PRESS RELEASE – PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, 12 April 2024, 12:00 CET – BioSenic (Euronext Brussels and Paris: BIOS),…
Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ETIRVINE, Calif., April 12, 2024 (GLOBE…
Cleanroom operator cutting tumor tissue Picture of Cbio cleanroom operator cutting tumor tissue for T-cell therapy production SØBORG, Denmark, April…
SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized…
IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a precision diagnostics company,…
– Bio-Rad expects to make equity investment in support of deal – Agreement provides for global exclusivity in transplant monitoring…
MIAMI, April 11, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing…